CUMBERLAND PHARMACEUTICALS INC Logo

CUMBERLAND PHARMACEUTICALS INC

Acquires and commercializes branded medicines for acute care, gastroenterology, and oncology.

CPIX | US

Overview

Corporate Details

ISIN(s):
US2307701092
LEI:
Country:
United States of America
Address:
1600 WEST END AVENUE, 37203 NASHVILLE,
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that acquires, develops, and commercializes a portfolio of branded, FDA-approved prescription medicines. The company is focused on improving patient care by delivering high-quality, innovative products designed to meet specific medical needs. Its commercialized products primarily serve the hospital acute care, gastroenterology, and oncology market segments, providing essential treatments to support medical professionals and their patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CUMBERLAND PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CUMBERLAND PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CUMBERLAND PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PRECISION BIOSCIENCES INC Logo
A clinical-stage company using ARCUS gene editing to treat cancer and rare genetic diseases.
United States of America DTIL
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
Prelude Therapeutics Inc Logo
Clinical-stage oncology company developing novel protein degraders and ADCs for cancer.
United States of America PRLD
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Prestige Consumer Healthcare Inc. Logo
Develops and markets leading over-the-counter brands for personal healthcare and wellness.
United States of America PBH
Processa Pharmaceuticals, Inc. Logo
Develops next-gen chemo and therapies for chronic and life-threatening diseases.
United States of America PCSA
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROKIDNEY CORP. Logo
Develops cellular therapies to preserve kidney function for patients with advanced Chronic Kidney Disease.
United States of America PROK
ProMIS Neurosciences Inc. Logo
Developing selective antibody therapies targeting toxic proteins in neurodegenerative diseases.
United States of America PMN

Talk to a Data Expert

Have a question? We'll get back to you promptly.